OnKure Therapeutics Q4 2024 GAAP EPS $(1.37) Misses $(0.74) Estimate

Benzinga · 6d ago
OnKure Therapeutics (NASDAQ:OKUR) reported quarterly losses of $(1.37) per share which missed the analyst consensus estimate of $(0.74) by 85.14 percent.